Skip to content

A clinical research on the treatment of functional gastrointestinal disorders with probiotic functional foods

A clinical research on the treatment of functional gastrointestinal disorders with probiotic functional foods

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119974
Enrollment
Unknown
Registered
2026-03-06
Start date
2026-03-30
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional gastrointestinaldisorders

Interventions

Intervention group 1:Take probiotic functional foods Haiyuanning orally for 14 days
Control group 1:Oral placebo A was taken for 14 days
Intervention group 2:Take probiotic functional foods Haiyuantong orally for 14 days
Control group 2:Oral placebo B was taken for 14 days
Intervention group 3:Take probiotic functional foods Far Voyage One orally for 14 days
Control group 3:Oral placebo C was taken for 14 days

Sponsors

Changhai Hospital of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18 to 50 years old. Gender not restricted. 2. According to the Rome IV criteria, diagnosed with any of the following conditions: a. Functional constipation; b. IBS - constipation type; c. Functional diarrhea; d. IBS - diarrhea type. 3. Voluntary participation in the study and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Has a history of organic intestinal diseases (inflammatory bowel disease, colon cancer, intestinal tuberculosis, etc.); 2. Combined with severe cardiovascular and cerebrovascular diseases, malignant tumors, autoimmune diseases, metabolic diseases or liver and kidney-related diseases; 3. Have taken antibiotics, probiotic preparations or other drugs that affect the evaluation of therapeutic effect within the past two weeks; 4. Pregnant or lactating women, or those with pregnancy plans within the last three months; 5. Allergic to the ingredients of the food used in the test; 6. Have participated in clinical trials using experimental drugs or devices within the past three months; 7. Other circumstances that the researchers consider unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Remission rate;

Secondary

MeasureTime frame
IBS-SSS; IBS-QoL;Depression, Anxiety, and Stress Scale;Bristol stool form scale,BSS;face rating scale, FRS;The degree of difficulty in defecation;

Countries

China

Contacts

Public ContactLi Zhaoshen

Changhai Hospital of Shanghai

li.zhaoshen@hotmail.com+86 21 3116 1355

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026